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Abstract: (E)-4-(3-Phenylisoxazol-5-yl)but-3-en-2-one was synthesized via the oxidative ring
opening reaction of 2-(5-methylfuran-2-yl)-1-phenylethanone oxime, followed by the iodine
mediated isomerization.
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1. Introduction
The isoxazole ring is a structural motif of numerous bioactive compounds, including several
marketed drugs [1]. Substituted isoxazoles are known as promising anticancer [2–5], antifungal [6],
antidepressant [7], antioxidant [8], and antituberculous agents [9]. Additionally, some of the isoxazoles
demonstrate herbicidal [10] and insecticidal [11] properties.
In 2017, Pinho e Melo et al. described a new synthesis of isoxazoles from tetrahydrofurooxazines
via the intermediate formation of oximes (Scheme 1) [12]. Main products of this acid-catalyzed reaction
were substituted 4-(isoxazol-5-yl)butan-2-ones 3. On the other hand, minor isoxazolylvinyl ketones
(E)-4 are of special interest, due to an active enone fragment, which can be utilized for the construction
of linked isoxazoles [13] and other new complex structures containing an isoxazole subunit [14].
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Scheme 1. Acid-catalyzed formation of isoxazolylvinyl ketones as minor products. 
Herein, we describe an easy approach to (E)-4-(3-phenylisoxazol-5-yl)but-3-en-2-one 4c, and its 
characterization by 1D and 2D NMR spectroscopy. 
2. Results and Discussion 
Oxime 2c was synthesized via the reaction of furfuryl ketone 5 with hydroxylamine 
hydrochloride, and sodium acetate in ethanol. The subsequent furan ring opening–isoxazole ring 
closure reaction of 2c under oxidative conditions [15,16] provided the target 
4-(3-phenylisoxazol-5-yl)but-3-en-2-one 4c in high yield as a mixture of (E,Z)-isomers (Scheme 2). 
.
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2. Results and Discussion
Oxime 2c was synthesized via the reaction of furfuryl ketone 5 with hydroxylamine hydrochloride,
and sodium acetate in ethanol. The subsequent furan ring opening–isoxazole ring closure reaction of
2c under oxidative conditions [15,16] provided the target 4-(3-phenylisoxazol-5-yl)but-3-en-2-one 4c in
high yield as a mixture of (E,Z)-isomers (Scheme 2).
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Scheme 2. Synthesis of compound 4c. 
Isoxazole (E)-4c was obtained in a pure form through iodine-mediated isomerization [17] and 
fully characterized (Scheme 3). 
  
Scheme 3. Isomerization (E,Z)-4c→(E)-4c. 
The structure of compound 4c was confirmed by 1H and 2D nuclear magnetic resonance 
spectroscopy: 1H-1H correlation spectroscopy (COSY), 1H-13C heteronuclear single-quantum 
correlation spectroscopy (HSQC), and 1H-13C heteronuclear multiple-bond correlation spectroscopy 
(HMBC) (Figures 1–3). In the 1H NMR spectrum of (E)-4c, signals of the vinyl protons α-H and β-H 
are observed at δH = 6.95 and 7.40 ppm, respectively, and have a coupling constant of 16.2 Hz, which 
indicates a (E)-configuration (Figure S1). In the 1H-13C HMBC spectrum, there are cross-peaks 
between the α-H proton and C-atom of the methyl group (δC 28.5 ppm) and isoxazole C(5) atom (δC 
166.3 ppm). The β-H proton correlates with carbonyl carbon atom at δC 197.0 ppm and isoxazole 
C(4) atom at δC 104.5 ppm. Cross-peaks between the proton H(4) at δH 6.80 ppm and β-C atom of 
the acetyl vinyl fragment at δC 125.4 ppm, and between protons of the methyl group at δH 2.41 ppm 
and α-C atom of the acetyl vinyl fragment at δC 130.8 ppm are observed as well. All key cross-peaks 
are presented in Table 1. 
Table 1. Cross-peaks in heteronuclear single-quantum correlation and heteronuclear multiple-bond 
correlation spectra of compound (E)-4c. 
 
1H, δ, ppm 
13C, δ, ppm 
HMQC HMBC 
7.40 (β-H) 125.4 104.5, 130.8, 166.3, 197.0 (C=O) 
6.95 (α-H) 130.8 28.5, 125.4, 166.3, 197.0 (C=O) 
6.80 (HIso) 104.5 125.4, 163.1, 166.3 
2.41 (CH3) 28.5 130.8, 197.0 (C=O) 
. .
Isoxazole (E)-4c as obtained in a pure for through iodine- ediated iso erization [17] and
fully characterized (Sche e 3).
l  , ,     
 .     
 .  , . 
 .         
    . 
I
c e e 3. Iso erization ( , )-4c ( )-4c.
The structure of compound 4c was confirmed by 1H and 2D nuclear magnetic resonance
spectroscopy: 1H-1H correlation spectroscopy (COSY), 1H-13C heteronuclear single-quantum
correlation spectroscopy (HSQC), and 1H-13C heteronuclear multiple-bond correlation spectroscopy
(HMBC) (Figures 1–3). In the 1H NMR spectrum of (E)-4c, signals of the vinyl protons α-H and β-H
are observed at δH = 6.95 and 7.40 ppm, respectively, and have a coupling constant of 16.2 Hz, which
indicates a (E)-configuration (Figure S1). In the 1H-13C HMBC spectrum, there are cross-peaks between
the α-H proton and C-atom of the methyl group (δC 28.5 ppm) and isoxazole C(5) atom (δC 166.3 ppm).
The β-H proton correlates with carbonyl carbon atom at δC 197.0 ppm and isoxazole C(4) atom at δC
104.5 ppm. Cross-peaks between the proton H(4) at δH 6.80 ppm and β-C atom of the acetyl vinyl
fragment at δC 125.4 ppm, and between protons of the methyl group at δH 2.41 ppm and α-C atom of
the acetyl vinyl fragment at δC 130.8 ppm are observed as well. All key cross-peaks are presented in
Table 1.
Table 1. Cross-peaks in heteronuclear single-quantum correlation and heteronuclear multiple-bond
correlation spectra of compound (E)-4c.
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In summary, we have suggested an effective route to (E)-4-(3-phenylisoxazol-5-yl)but-3-en-2-one
employing oxidative RORC reaction of furfuryl ketone oxime. The exploration of the reaction scope is
underway in our laboratory.
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3. Materials and Methods  
All commercial products and solvents were used without further purification (Fisher Scientific, 
Loughborough, UK). All reactions were run under the air unless noted otherwise. 
The reactions under microwave irradiation were conducted in Microwave Synthesis Reactor 
«Biotage® Robot Eight» (Biotage AB, Uppsala, Sweden) using sealed microwave reaction vessels. 
TLC analyses were performed on Merck 60 F254 aluminum plates in combination with UV detection 
(254 nm). Flash chromatography was performed on silica gel 200–300 mesh (Merck, Darmstadt, 
Germany) using mixture EtOAc/i-hexane as eluents. Melting points were determined on a 
Mel-Temp II Laboratory Devices apparatus (Triad Scientific Manasquan, Manasquan, NJ, USA); the 
values are uncorrected. NMR spectra were recorded on a Bruker AV-600 (1H NMR at 600 MHz and 
13C NMR at 151 MHz,) and Bruker AV-400 (1H NMR at 400 MHz and 13C NMR at 101 MHz) 
spectrometers (Bruker GmbH, Mannheim, Germany). Proton chemical shifts (δ) are reported in parts 
per million (ppm) relative to tetramethylsilane (TMS), with the solvent resonance employed as the 
internal standard (CDCl3 δ = 7.26 ppm). Data are reported as follows: chemical shift, multiplicity (s = 
singlet, d = doublet, t = triplet, q = quartet, m = multiplet, dd = doublet of doublets, dt = doublet of 
triplets), coupling constants (J) and integration. Coupling constants (J) are reported in Hertz (Hz). 
Carbon chemical shifts are reported in ppm from tetramethylsilane (TMS), with the solvent 
resonance as the internal standard (CDCl3 δ = 77.16 ppm). 
IR spectra were measured on PerkinElmer Spectrum BX spectrophotometer (NaCl plates, 
PerkinElmer LAS GmbH, Rodgau, Germany). HRMS-ESI spectra were recorded at The Mass 
Spectroscopy Laboratory, Chair of Organic Chemistry, Friedrich-Alexander University of 
Erlangen-Nuremberg.  
Starting furfuryl ketone 5 was obtained according to the published procedure [18]. 
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3. Materials and Methods
All commercial products and solvents were used without further purification (Fisher Scientific,
Loughborough, UK). All reactions were run under the ir unless noted therwise.
The reactions under microwave irradiation were conducted in Microwave Synthesis Reactor
«Biotage® Robot Eight» (Biotage AB, Uppsala, Sweden) using sealed microwave reaction vessels.
TLC analyses were performed on Merck 60 F254 aluminum plates in combination with UV detection
(254 nm). Flash chromatography was performed on silica gel 200–300 mesh (Merck, Darmstadt,
Germany) using mixture EtOAc/i-hexane as eluents. Melting points were determined on a Mel-Temp
II Laboratory Devices apparatus (Triad Scientific Manasquan, Manasquan, NJ, USA); the values are
uncorrected. NMR spectra were recorded on a Bruker AV-600 (1H NMR at 600 MHz and 13C NMR at
151 MHz,) and Bruker AV-400 (1H NMR at 400 MHz and 13C NMR at 101 MHz) spectrometers (Bruker
GmbH, Mannheim, Germany). Proton chemical shifts (δ) are reported in parts per illion (ppm)
relative to tetramethylsilane (TMS), with the solvent resonance employed as the internal standard
(CDCl3 δ= 7.26 ppm). Data are reported as follows: chemical shift, multiplicity (s = singlet, d = doublet,
t = triplet, q = quartet, m = multiplet, dd = doublet of doublets, dt = doublet of triplets), coupling
constants (J) and integration. Coupling constants (J) are reported in Hertz (Hz). Carbon chemical shifts
are reported in ppm from tetramethylsilane (TMS), with the solvent resonance as the internal standard
(CDCl3 δ = 77.16 ppm).
IR spectra were measured on PerkinElmer Spectrum BX spectrophotometer (NaCl plates,
PerkinElmer LAS GmbH, Rodgau, Germany). HRMS-ESI spectra were recorded at The Mass Spectroscopy
Laboratory, Chair of Organic Chemistry, Friedrich-Alexander University of Erlangen-Nuremberg.
Starting furfuryl ketone 5 was obtained according to the published procedure [18].
2-(5-Methylfuran-2-yl)-1-phenylethan-1-one oxime (2c)
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Hydroxylamine hydrochloride (2 mmol) and anhydrous NaOAc (4 mmol) were added to a
solution of furfuryl ketone 5 (2 mmol) in ethanol (5 mL), and the mixture was stirred for 24 h at 80 ◦C
(TLC and LC-MS control). Then, the reaction mixture was poured into H2O (100 mL) and extracted
with EtOAc (4 × 25 mL). The combined organic phases were washed with brine, dried over anhydrous
Na2SO4, filtered, and evaporated under reduced pressure. The resulting crude product was purified
by flash chromatography using EtOAc/i-Hex as eluents.
Yield 0.61 g (100%). White solid. M.p. 90–92 ◦C. 1H NMR (600 MHz, CDCl3): δ = 7.69–7.67 (m,
2H), 7.37–7.36 (m, 3H), 5.92 (d, J = 3.0 Hz, 1H), 5.83 (m, 1H), 4.13 (s, 2H), 2.24 (s, 3H) ppm. 13C NMR
(101 MHz, CDCl3): δ = 155.2, 150.9, 147.9, 135.3, 129.4, 128.5, 126.4, 107.5, 106.3, 25.5, 13.6 ppm. IR
(NaCl): 3241, 2922, 1568, 1495, 1461, 1321, 1168, 1016, 960 cm−1. HRMS (ESI): m/z calcd. for C13H13NO2
[M-H]+: 214.0868; found: 214.0862.
(E,Z)-4-(3-Phenylisoxazol-5-yl)but-3-en-2-one ((E,Z)-4c)
m-CPBA (77% w/w, 0.135 g, 0.6 mmol) was added to a solution of oxime 2c (0.5 mmol) in DCM
(2 mL) at 0 ◦C. The reaction mixture was stirred at the same temperature for 1 h. Then TFA (0.038 mL,
0.05 mmol) was added. The reaction mixture was allowed to reach room temperature and stirred for
20 h. Once the reaction was complete, the mixture was washed with Na2S2O3 solution three times, and
then with brine. DCM was dried over anhydrous Na2SO4, filtered, and evaporated under reduced
pressure to give a pure (E,Z)-4.
(Z)-4-(3-Phenylisoxazol-5-yl)but-3-en-2-one ((Z)-4c)
In a mixture with (E)-isomer. 1H NMR (600 MHz, CDCl3): δ = 7.87–7.86 (m, 2H), 7.69 (s, 1H),
7.48–7.44 (m, 3H), 6.74 (d, J = 12.8 Hz, 1H), 6.43 (d, J = 12.8 Hz, 1H), 2.37 (s, 3H) ppm. 13C NMR
(101 MHz, CDCl3): δ = 197.8, 166.0, 163.2, 130.8, 130.4, 130.1, 128.9, 126.8, 123.5, 106.0, 31.5 ppm.
Isomerization (E,Z)-4→(E)-4
Microwave reaction vessel was charged with (E,Z)-4c (0.2 mmol), I2 (0.0034 g, 0.013 mmol), and
toluene (5 mL). The reaction mixture was stirred at 140 ◦C in a microwave reactor for 2 h. After
completion of the reaction, toluene and iodine were removed under reduced pressure to afford
pure (E)-3a.
(E)-4-(3-Phenylisoxazol-5-yl)but-3-en-2-one) (E)-4c)
Yield 0.034 g (80%). White solid. M.p. 130–132 ◦C. 1H NMR (600 MHz, CDCl3): δ = 7.83–7.81
(m, 2H), 7.49–7.47 (m, 3H), 7.40 (d, J = 16.2 Hz, 1H), 6.95 (d, J = 16.2 Hz, 1H), 6.80 (s, 1H), 2.41 (s, 3H)
ppm. 13C NMR (151 MHz, CDCl3): δ = 197.0, 166.3, 163.1, 130.8, 130.4, 129.1, 128.4, 126.8, 125.4, 104.5,
28.5 ppm. IR (NaCl): 1664 (C=O), 1560, 1439, 1268, 983, 952, 769 cm−1. HRMS (ESI): m/z calcd. for
C13H11NO2 [M + H]+: 214.0868; found: 214.0861.
Supplementary Materials: The following are available online, Figure S1: 1H NMR spectrum of compound 2c,
Figure S2: 13C NMR spectrum of compound 2c, Figure S3: 1H NMR spectrum of compound (E)-4c, Figure S4: 13C
NMR spectrum of compound (E)-4c, Figure S5: 1H NMR spectrum of compound (Z)-4c, Figure S6: 13C NMR
spectrum of the compound (Z)-4c.
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